Trial · NCT01349322
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With In-breast Recurrence (Local Failure) | Whole Breast Irradiation + Sequential Boost (Arm 1) | 2.0 | 95% Confidence Interval 1.4 to 2.9 | percentage of participants | |
| Percentage of Participants With In-breast Recurrence (Local Failure) | Hypofractionated Whole Breast Irradiation + Concurrent Boost (Arm 2) | 1.9 | 95% Confidence Interval 1.3 to 2.7 | percentage of participants | |
| Percentage of Participants Alive | Whole Breast Irradiation + Sequential Boost | 95.7 | 95% Confidence Interval 94.4 to 96.9 | percentage of participants | |
| Percentage of Participants Alive | Hypofractionated Whole Breast Irradiation + Concurrent Boost | 95.1 | 95% Confidence Interval 93.8 to 96.4 | percentage of participants | |
| Percentage of Participants Alive Without Disease | Whole Breast Irradiation + Sequential Boost | 90.2 | 95% Confidence Interval 88.5 to 92.0 | percentage of participants | |
| Percentage of Participants Alive Without Disease | Hypofractionated Whole Breast Irradiation + Concurrent Boost | 88.5 | 95% Confidence Interval 86.7 to 90.4 | percentage of participants | |
| Percentage of Participants Alive Without Distant Disease | Whole Breast Irradiation + Sequential Boost | 91.5 | 95% Confidence Interval 89.9 to 93.2 | percentage of participants | |
| Percentage of Participants Alive Without Distant Disease | Hypofractionated Whole Breast Irradiation + Concurrent Boost | 90.2 | 95% Confidence Interval 88.4 to 91.9 | percentage of participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Whole Breast Irradiation + Sequential Boost | Grade 1 | 427 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Hypofractionated Whole Breast Irradiation + Concurrent Boost | Grade 1 | 554 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Whole Breast Irradiation + Sequential Boost | Grade 2 | 379 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Hypofractionated Whole Breast Irradiation + Concurrent Boost | Grade 2 | 290 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Whole Breast Irradiation + Sequential Boost | Grade 3 | 34 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Hypofractionated Whole Breast Irradiation + Concurrent Boost | Grade 3 | 35 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Whole Breast Irradiation + Sequential Boost | Grade 4 | 2 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Hypofractionated Whole Breast Irradiation + Concurrent Boost | Grade 4 | 4 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Whole Breast Irradiation + Sequential Boost | Grade 5 | 0 | Participants | |
| Number of Participants by Highest Grade Adverse Event Reported as Definitely, Probably, or Possibly Related to Protocol Treatment | Hypofractionated Whole Breast Irradiation + Concurrent Boost | Grade 5 | 0 | Participants | |
| Change in Breast Cancer Treatment Outcome Scale (BCTOS) Cosmesis Subscale Score From Baseline to 3 Years | Whole Breast Irradiation + Sequential Boost (Arm 1) | 0.16 | 95% Confidence Interval 0.08 to 0.24 | score on a scale | |
| Change in Breast Cancer Treatment Outcome Scale (BCTOS) Cosmesis Subscale Score From Baseline to 3 Years | Hypofractionated Whole Breast Irradiation + Concurrent Boost (Arm 2) | 0.18 | 95% Confidence Interval 0.11 to 0.25 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01349322/results